When to Check Digoxin Level After Outpatient Initiation
Check the serum digoxin level at steady state, which occurs approximately 1-3 weeks after starting digoxin, depending on the patient's renal function—specifically after approximately 5 half-lives of the drug. 1
Timing Based on Renal Function
The time to reach steady-state digoxin concentrations is directly dependent on renal clearance:
- Normal renal function (CrCl ≥60 mL/min): Steady state achieved in approximately 7-11 days
- Moderate renal impairment (CrCl 30-60 mL/min): Steady state achieved in approximately 11-14 days
- Severe renal impairment (CrCl <30 mL/min): Steady state achieved in approximately 14-22 days 1
The FDA label explicitly states that steady-state serum digoxin concentrations will be achieved in approximately five half-lives of the drug for the individual patient, which depending upon renal function, will take between 1 and 3 weeks. 1
Critical Sampling Guidelines
When you do check the level, timing of the blood draw is crucial to avoid misleading results:
- Draw the sample immediately before the next scheduled dose (trough level), or
- Wait at least 6-8 hours after the last dose if pre-dose sampling is not possible 1, 2, 3, 4
This 6-8 hour minimum is essential because digoxin requires adequate time for equilibration between serum and tissue. Samples drawn earlier will show falsely elevated concentrations that do not reflect true tissue levels and can lead to inappropriate dose reductions 3.
Target Therapeutic Range
Current evidence strongly supports maintaining lower digoxin concentrations than historically recommended:
- Target range: 0.5-0.9 ng/mL 5
- Avoid levels >1.0 ng/mL, as retrospective analyses show increased mortality above this threshold without additional benefit 6, 7
- The older "therapeutic range" of 0.8-2.0 ng/mL is outdated and associated with increased toxicity 8
Clinical Context Matters More Than the Number
The serum digoxin concentration should always be interpreted in the overall clinical context, and an isolated measurement should not be used alone as the basis for increasing or decreasing the dose. 1 Toxicity can occur at levels below 2.0 ng/mL, especially with:
- Hypokalemia
- Hypomagnesemia
- Hypothyroidism
- Impaired renal function
- Low lean body mass
- Advanced age (>70 years)
- Concomitant medications that increase digoxin levels (amiodarone, dronedarone, verapamil, quinidine, clarithromycin, erythromycin, itraconazole, cyclosporine, propafenone) 5
Common Pitfalls to Avoid
- Don't check levels too early: Checking before steady state (within the first week in patients with normal renal function) provides no useful information for dose adjustment
- Don't sample too soon after a dose: Levels drawn <6 hours after administration are falsely elevated and do not correlate with clinical effect or toxicity 2, 3, 4
- Don't ignore physical activity: Everyday physical activity can decrease serum digoxin by 0-75% due to increased skeletal muscle binding; ideally have patients rest supine for 2 hours before sampling in the outpatient setting 9, 10
- Don't use outdated therapeutic ranges: Targeting levels of 1.2-2.0 ng/mL increases mortality risk 8
Practical Algorithm
- Start digoxin at 0.125-0.25 mg daily (lower dose if age >70, renal impairment, or low lean body mass) 5
- Calculate expected time to steady state based on renal function (1-3 weeks)
- Check first digoxin level at steady state (7-22 days depending on renal function)
- Draw trough level (immediately before next dose) or wait ≥6-8 hours after last dose
- Target 0.5-0.9 ng/mL for heart failure; adjust dose if needed
- Recheck level 1-3 weeks after any dose adjustment (again based on renal function)
The 2013 ACC/AHA guidelines note that in the DIG trial, mean serum digoxin concentrations at 1 month and 12 months were 1.01 ± 0.47 ng/mL and 0.97 ± 0.43 ng/mL respectively, demonstrating that steady-state monitoring at approximately 1 month is standard practice 5, 1.